참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Pyridine | HCID 1049 | — |
| 반응물 | 1-(3-Hydroxy-4-methoxyphenyl)ethanone | HCID 95693 | — |
| 반응물 | O-(benzo[c][1,2,5]oxadiazol-5-ylmethyl)hydroxylamine hydrochloride | HCID 66760966 | — |
| 용매 | Ethanol | HCID 702 | — |
| 생성물 | 1-(3-hydroxy-4-methoxyphenyl)ethanone-O-[(benzo[c][1,2,5]oxadiazol-5-yl)methyl]oxime | HCID 131730841 | 90.2% |
반응 단계
A solution of 3-hydroxy-4-methoxyacetophenone (0.070 g, 0.421 mmol), (benzo[c][1,2,5]oxadiazol-5-yl)methoxyamine hydrochloride (0.126 g, 0.625 mmol) and pyridine (0.16 ml, 1.98 mmol) in ethanol (6 ml) was stirred at reflux under nitrogen for 4 h and cooled to room temperature. The solution was concentrated to a yellow oil which was diluted with water. The resultant suspension was extracted with dichloromethane (×3). The combined organic phases were washed with water, dried over magnesium sulphate, filtered and concentrated to a yellow oil. The crude product was purified by column chromatography (SiO2), eluting with 8:2 petrol/ethyl acetate, to give a slightly sticky solid which was further triturated with petroleum spirit (40-60°), to give 1-(3-hydroxy-4-methoxyphenyl)ethanone-O -[(benzo[c][1,2,5]oxadiazol-5-yl)methyl]oxime (CP9-33) as a light yellow solid (0.119 g, 90%).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08536157B2 |
|---|
| 출처 데이터셋 | uspto-grants-2013_09 |
|---|
| ORD ID | ord-5e2e2cf38815438bac726ffa7b23f1b6 |
|---|
| 출처 메모 | uspto-grants-2013_09 |
|---|